Click (CLIK) Stock Price, News & Analysis

Company Overview

Click Therapeutics, Inc. (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review. Several of its lead digital therapeutics have earned Breakthrough Device designation from the U.S. Food and Drug Administration and have pursued CE marking for commercialization in Europe. The company collaborates with pharmaceutical partners, academic institutions and healthcare providers to integrate its digital products into clinical pathways and to collect real-world evidence supporting safety and efficacy.

Headquartered in New York City, Click operates in the United States with strategic alliances in select international markets. Its leadership team draws on deep experience in digital health innovation, neuroscience research and pharmaceutical development. Click continues to invest in research and development, aiming to expand its pipeline into new therapeutic areas and to scale adoption of its digital therapeutics globally.

Key Stats

• Today's Range: $6.45 to $7.00
• 50-Day Range: $7.01 to $10.77
• 52-Week Range: $4.80 to $102.90
• Volume: 37,328 shs
• Average Volume: 161,476 shs
• Market Capitalization: $7.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

CLIK Stock Analysis - Frequently Asked Questions

How have CLIK shares performed this year?

Click's stock was trading at $35.70 at the start of the year. Since then, CLIK shares have decreased by 81.1% and is now trading at $6.7650.

When did Click's stock split?

Click shares reverse split before market open on Friday, October 10th 2025.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Click IPO?

Click (CLIK) raised $6 million in an initial public offering (IPO) on Wednesday, October 9th 2024. The company issued 1,500,000 shares at $4.00 per share. R.F. Lafferty & Co. and Revere Securities served as the underwriters for the IPO.

How do I buy shares of Click?

Shares of CLIK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: BUSINESS INFO SVC
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:CLIK
• CIK: 2020027
• Web: N/A
• Phone: 852 3758 2780
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $5.66 million
• Price / Sales: 1.38
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $10.61 per share
• Price / Book: 0.64

Miscellaneous

• Outstanding Shares: 1,150,000
• Free Float: N/A
• Market Cap: $7.79 million
• Optionable: N/A
• Beta: N/A